Milan Kvapil s.r.o.
- Address
- Michnova 1622/4, Chodov, 149 00 Prague, Czechia
Milan Kvapil s.r.o. - Cardiometabolic Research Center
Milan Kvapil s.r.o. is a specialized clinical research center with extensive expertise in cardiometabolic disorders, focusing on the intersection of cardiovascular disease, metabolic syndrome, and obesity-related conditions. The center conducts advanced Phase II and Phase III trials investigating novel therapeutic approaches for complex metabolic conditions that significantly impact patient quality of life and long-term health outcomes.
- Heart failure prevention and cardiovascular death reduction in high-risk populations
- Obesity and overweight management in patients with and without Type 2 diabetes
- Chronic kidney disease and lipid metabolism disorders
- Obstructive sleep apnea associated with metabolic dysfunction
The center demonstrates particular strength in evaluating combination therapies and weight management interventions, including trials of emerging drug classes such as dual-acting peptides and aldosterone synthase inhibitors. Research protocols extend beyond traditional metabolic conditions to include severe hypertriglyceridemia, Graves' disease, and the complex relationship between obesity and comorbid conditions. The center's comprehensive approach addresses both glycemic control and weight reduction, recognizing the multifaceted nature of cardiometabolic health and the need for integrated treatment strategies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 therapeutic areas and 15 of 16 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1AstraZeneca AB3active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB4trials
lock +6 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Milan Kvapil s.r.o.
lock Showing 1 of 20 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease | Immunovant Sciences GmbH | Phase II | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 16 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bi 690517 | 2 | Unknown | 2025-08-28 | 2025-10-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.